Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma

Pettengell R, Johnsen HE, et al. Support Care Cancer 2011; [DOI:10.1007/s00520-011-1306-6] [Epub ahead of print]

http://www.ncbi.nlm.nih.gov/pubmed/22101611

• see summary in section on related research, members' research

 

Incidence of neutropenia, chemotherapy delivery, and use of colony-stimulating factor in patients with non-Hodgkin lymphoma of different age groups

Pettengell R and Schwenkglenks M Leuk Lymphoma 2011; 52(6):1133-6

http://www.ncbi.nlm.nih.gov/pubmed/21314247

• see summary in section on prospective study

 

Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia Study Schwenkglenks M, Pettengell R, Jackisch C, et al. Support Care Cancer 2011; 19(4):483-90

http://www.ncbi.nlm.nih.gov/pubmed/20306092

• see summary in section on prospective study

 

Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery

Schwenkglenks M, Pettengell R, Szucs TD, et al. J Hematol & Oncol 2010; 3:27

http://www.ncbi.nlm.nih.gov/pubmed/20723212

• see summary in section on related research, member's research

 

Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma: data from the INC-EU Prospective Observational European Neutropenia Study

Pettengell R, Bosly A, Szucs TD, et al. Br J Haematol 2009; 144(5):677-85

http://www.ncbi.nlm.nih.gov/pubmed/19055662

• see summary in section on prospective study